The Key to Their Hearts: The Indispensable Role of the Primary Care-Giver in the Management of Patients Post-MI

Faculty

Needs Statement

Following a coronary event, nearly 25% of patients will die within 1 year and about the same number will have another episode within 6 years. The high morbidity and mortality rates associated with acute coronary syndromes (ACS) call for improved care for these patients and require that all clinicians have an awareness of the latest guidelines for post-ACS management. This newsletter will focus on modifiable and nonmodifiable risk factors for ACS, risk stratification methods and roadblocks to implementation of these methods in everyday practice.

Target Audience

This activity is designed for primary care clinicians and other healthcare professionals interested in the management of patients with ACS.

Objectives

At the conclusion of this activity, participants should be better able to:
1.  Assess the impact of modifiable and nonmodifiable risk factors for ACS on risk stratification.

Accreditation

CME
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and ACCELMED. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

Dr. Gurbel has served as a consultant to Boston Scientific, Medtronic, ThromboScience; and has received research support from AstraZeneca, Bayer, Haemoscope and NIH, Schering-Plough Corporation/Millennium Pharmaceuticals, Inc.

Dr. Toth has served on the speaker's bureau for Daiichi Sankyo, Inc.

None of the planners involved in this activity report any relevant financial relationships with commercial interests.

Activity Sponsorship

This activity is jointly sponsored by the University of Kentucky and ACCELMED. Supported by an unrestricted educational grant from Lilly USA, LLC and Daiichi Sankyo, Inc.